Tripterygium wilfordii Hook F extract - Phytomedics

Drug Profile

Tripterygium wilfordii Hook F extract - Phytomedics

Alternative Names: PMI-001; TwHF extract

Latest Information Update: 17 Aug 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Phytomedics
  • Class Anti-inflammatories; Antirheumatics; Herbal medicines; Traditional-Chinese-medicine
  • Mechanism of Action Cyclo-oxygenase 2 inhibitors; Interleukin 2 inhibitors; Nitric oxide synthase type II inhibitors; Tumour necrosis factor alpha inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Rheumatoid arthritis

Most Recent Events

  • 11 Nov 2010 Phytomedics receives grant under the Qualifying Therapeutic Discovery Project Program for development of PMI 001 in Rheumatoid arthritis
  • 21 Aug 2009 Clinical development is ongoing in USA
  • 19 Aug 2009 Final efficacy and adverse events data from a phase II trial in Rheumatoid arthritis released by Phytomedics
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top